These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25548800)

  • 1. Whole genome sequencing as a means to assess pathogenic mutations in medical genetics and cancer.
    Royer-Bertrand B; Rivolta C
    Cell Mol Life Sci; 2015 Apr; 72(8):1463-71. PubMed ID: 25548800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives.
    Precone V; Del Monaco V; Esposito MV; De Palma FD; Ruocco A; Salvatore F; D'Argenio V
    Biomed Res Int; 2015; 2015():161648. PubMed ID: 26665001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Disease Susceptibility Alleles in the Next Generation Sequencing Era.
    DiStefano JK; Kingsley CB
    Methods Mol Biol; 2018; 1706():3-16. PubMed ID: 29423790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge for the next generation of medical geneticists.
    Frebourg T
    Hum Mutat; 2014 Aug; 35(8):909-11. PubMed ID: 24838402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of cancer genome sequencing.
    Ku CS; Cooper DN; Roukos DH
    World J Gastroenterol; 2013 Apr; 19(13):2011-8. PubMed ID: 23599619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VarAFT: a variant annotation and filtration system for human next generation sequencing data.
    Desvignes JP; Bartoli M; Delague V; Krahn M; Miltgen M; Béroud C; Salgado D
    Nucleic Acids Res; 2018 Jul; 46(W1):W545-W553. PubMed ID: 29860484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing in the clinic: promises and challenges.
    Xuan J; Yu Y; Qing T; Guo L; Shi L
    Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders.
    Rabbani B; Mahdieh N; Hosomichi K; Nakaoka H; Inoue I
    J Hum Genet; 2012 Oct; 57(10):621-32. PubMed ID: 22832387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potential causative mutations in human coding and noncoding genome with the interactive software BasePlayer.
    Katainen R; Donner I; Cajuso T; Kaasinen E; Palin K; Mäkinen V; Aaltonen LA; Pitkänen E
    Nat Protoc; 2018 Nov; 13(11):2580-2600. PubMed ID: 30323186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer whole-genome sequencing: present and future.
    Nakagawa H; Wardell CP; Furuta M; Taniguchi H; Fujimoto A
    Oncogene; 2015 Dec; 34(49):5943-50. PubMed ID: 25823020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Centers for Mendelian Genomics: a new large-scale initiative to identify the genes underlying rare Mendelian conditions.
    Bamshad MJ; Shendure JA; Valle D; Hamosh A; Lupski JR; Gibbs RA; Boerwinkle E; Lifton RP; Gerstein M; Gunel M; Mane S; Nickerson DA;
    Am J Med Genet A; 2012 Jul; 158A(7):1523-5. PubMed ID: 22628075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the Clinical Value of a Genomic Diagnosis in the Era of Next-Generation Sequencing.
    Strande NT; Berg JS
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():303-32. PubMed ID: 27362341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Whole-genome sequencing and its application in the research and diagnoses of genetic diseases].
    Shao Q; Jiang Y; Wu J
    Yi Chuan; 2014 Nov; 36(11):1087-98. PubMed ID: 25567867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of tools for variant analysis of next-generation genome sequencing data.
    Pabinger S; Dander A; Fischer M; Snajder R; Sperk M; Efremova M; Krabichler B; Speicher MR; Zschocke J; Trajanoski Z
    Brief Bioinform; 2014 Mar; 15(2):256-78. PubMed ID: 23341494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point mutations as a source of de novo genetic disease.
    de Ligt J; Veltman JA; Vissers LE
    Curr Opin Genet Dev; 2013 Jun; 23(3):257-63. PubMed ID: 23453690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
    Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research and clinical applications of cancer genome sequencing.
    Ku CS; Cooper DN; Ziogas DE; Halkia E; Tzaphlidou M; Roukos DH
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):3-10. PubMed ID: 23108289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic Mutagenesis in Mammals and Its Implications for Human Disease and Aging.
    Zhang L; Vijg J
    Annu Rev Genet; 2018 Nov; 52():397-419. PubMed ID: 30212236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.